The importance of influenza viruses in respiratory infections in the Middle East, including Iraq, has been historically overlooked. Nowadays, with the pandemic of corona virus disease 2019, the importance of prevention from other respiratory diseases, such as seasonal influenza, can be a critical step in the health management system. Therefore, this study aimed to evaluate the prevalence and seasonal occurrence of influenza viruses in the Iraqi population presented with influenza‐like illness (ILI) or severe acute respiratory infection (SARI)within2015-2017. Moreover, this study was conducted to identify the periods with increased influenza transmission for vaccination recommendations in Iraq. In the present study, we presented the cases of infection by influenza A or B viruses. To test influenza virus types A (H1N1 and H3N2) and B, 1,359 throat and nasal swabs were collected from patients with ILI or SARI. Ribonucleic acid was extracted and amplified using a set of primers and probes. The frequency rates of infection were obtained at 1,616 (45%) and 1974 (55%) in females and males, respectively. The mean age of the participants was estimated at 31.71±22.68 with a minimum and maximum ages of 1 month and 96 years, respectively. It was revealed that influenza virus type A was the most predominant with an incidence of 16.2%, followed by type B with 0.33% incidence. It was also found that December was the most prevalent month of being infected by influenza viruses types A and B (30.02% and 0.48%, respectively). Vaccination in September would likely protect the highest number of patients. It was clear that the influenza A virus was predominant over type B. In Iraq, influenza A and B viruses were found in a large percentage of ILI and SARI cases. Additionally, males were reported to be more likely to become infected than females. |
- Heymann DL, Association APH. Control of Communicable Diseases Manual: Am J Public Health; 2004.
- Brammer TL, Cox NJ, Fukuda K, Hall HE, Klimov A, Murray EL, et al. Surveillance for Influenza--United States, 1997-98, 1998-99, and 1999-00 Seasons: CDC; 2002.
- Finkelman BS, Viboud C, Koelle K, Ferrari MJ, Bharti N, Grenfell BT. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS One. 2007;2(12):e1296.
- CDC, (U.S.) CfDCaP. Influenza. Epidemiol Prev Vaccine-Preventable Dis. 2015:187-208.
- Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-86.
- (CDC) CfDCaP. Update: swine influenza A (H1N1) infections. California and Texas. MMWR Morb Mortal Wkly Rep. 2009;58(16):435-7.
- Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282(15):1440-6.
- Weber MW, Mulholland EK, Greenwood BM. Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health. 1998;3(4):268-80.
- (CDC) CfDCaP. novel influenza A (H1N1) virus infection - Mexico. MMWR Morb Mortal Wkly Rep. 2009;58(21):585-9.
- Cooney MK, Fox JP, Hall CE. The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Am J Epidemiol. 1975;101(6):532-51.
- CDC. The flu season. Atlanta, GA: US Department of Health and Human Services, CDC. 2015.
- Sun S, Fu C, Cong J, Li Y, Xie S, Wang P. Epidemiological features and trends of influenza incidence in mainland China: A population-based surveillance study from 2005 to 2015. Int J Infect Dis. 2019;89:12-20.
- Tokars JI, Olsen SJ, Reed C. Seasonal Incidence of Symptomatic Influenza in the United States. Clin Infect Dis. 2018;66(10):1511-8.
- Barrat F, Lesourd B, Boulouis HJ, Thibault D, Vincent-Naulleau S, Gjata B, et al. Sex and parity modulate cytokine production during murine ageing. Clin Exp Immunol. 1997;109(3):562-8.
- Lorenzo ME, Hodgson A, Robinson DP, Kaplan JB, Pekosz A, Klein SL. Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice. Vaccine. 2011;29(49):9246-55.
- Cohen C, Moyes J, Tempia S, Groome M, Walaza S, Pretorius M, et al. Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. PLoS One. 2015;10(3):e0118884.
|